Divergent Roles of Angiotensin II AT 1 and AT 2 Receptors in Modulating Coronary Microvascular Function
Authors:
- 21 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 92 (3) , 322-329
Abstract
Angiotensin II (Ang II) is a potent vasoconstrictor in the peripheral circulation and has been implicated in many cardiovascular diseases associated with elevated oxidative stress. However, its direct vasomotor action and its linkage to oxidative stress–induced vascular dysfunction in the coronary microcirculation remain elusive. In this study, we directly assessed the vasomotor action of Ang II in isolated porcine coronary arterioles and also examined whether Ang II can modulate endothelium-dependent nitric oxide (NO)-mediated dilation via superoxide production. Ang II evoked vasoconstriction at a low concentration (1 nmol/L) and dilations at higher concentrations (>10 nmol/L). Ang II type 1 (AT 1 ) receptor antagonist losartan abolished vasoconstriction, whereas Ang II type 2 (AT 2 ) receptor antagonist PD 123319 eliminated vasodilation. Adenosine stimulated a significant arteriolar NO production and dilation. NO synthase inhibitor N G -monomethyl- l -arginine (L-NMMA) abolished stimulated NO production and attenuated vasodilation. Pretreating vessels with a subvasomotor concentration of Ang II (0.1 nmol/L, 60 minutes) mimicked inhibitory effects of L-NMMA. Ang II–mediated inhibition was not observed in the presence of L-NMMA or after endothelial removal but was prevented by losartan, superoxide scavenger TEMPOL, or NADPH oxidase inhibitor apocynin. Dihydroethidium staining showed that Ang II elicited losartan- and TEMPOL-sensitive superoxide production in arterioles. These results demonstrate that Ang II evokes AT 1 receptor–mediated vasoconstriction and AT 2 receptor–mediated vasodilation of coronary arterioles. Ang II at a subvasomotor level impairs endothelium-dependent NO-mediated dilation attributable to elevated superoxide production via AT 1 receptor activation of NADPH oxidase. These data may partly explain the impaired coronary flow regulation in heart diseases associated with an upregulated renin-angiotensin system.Keywords
This publication has 17 references indexed in Scilit:
- AT2receptor-mediated vasodilation in the heart: effect of myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2001
- Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide‐mediated vasodilatory functionThe FASEB Journal, 2001
- The renin angiotensin system as a risk factor for coronary artery diseaseCurrent Atherosclerosis Reports, 2001
- Differential role of angiotensin II receptor subtypes on endothelial superoxide formationBritish Journal of Pharmacology, 2000
- Endothelial dysfunction and peroxynitrite formation are early events in angiotensin‐induced cardiovascular disordersThe FASEB Journal, 2000
- Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidasesCardiovascular Research, 1999
- Impact of Coronary Risk Factors on Contribution of Nitric Oxide and Adenosine to Metabolic Coronary Vasodilation in HumansJACC, 1998
- Effects of Angiotensin II on Canine and Porcine Coronary Epicardial and Resistance ArteriesJournal of Vascular Research, 1994
- Coronary reactive hyperaemia and coronary dilator action of adenosine during intracoronary infusion of Angiotensin IIBasic Research in Cardiology, 1979
- Estimation of Angiotensin II Concentration in Human Plasma by Radioimmunoassay. Some Applications to Physiological and Clinical StatesEuropean Journal of Clinical Investigation, 1971